Monoclonal targeting Plasmodium falciparum circumsporozoite protein (PfCSP)

"We conducted a phase 2 trial to assess the safety and efficacy of a single intravenous infusion of CIS43LS against P. falciparum infection in healthy adults in Mali over a 6-month malaria season"

#Plasmodium #Malaria #MonoclonalAntibody #clinicaltrial

https://www.nejm.org/doi/full/10.1056/NEJMoa2206966?query=featured_home